RIEFLIN WILLIAM JL 4
4 · RAPT Therapeutics, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
RIEFLIN WILLIAM JL
Director
Transactions
- Award
Stock Option (right to buy)
2022-03-31$16.80/sh+5,207$87,478→ 5,207 totalExercise: $21.99Exp: 2032-03-30→ Common Stock (5,207 underlying)
Footnotes (2)
- [F1]The shares subject to the option vest in four equal quarterly installments on the last day of each fiscal quarter in 2022 with the first installment vesting on March 31, 2022, provided that the reporting person is in service as a director on each such vesting date.
- [F2]This option was issued to the reporting person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of an annual cash retainers for service on the Board of Directors and committees thereof in the aggregate amount of $87,500.